Placeholder Banner

BIO Testifies to House Agriculture Subcommittee on the Next Farm Bill

March 9, 2017

BIO President & CEO Jim Greenwood testified in front of the U.S. House Committee on Agriculture Subcommittee on Commodity Exchanges, Energy, and Credit at a hearing titled, The Next Farm Bill: Examining Rural Development & Energy Programs.

BIO supports public policies – including government funding for key agencies and programs – to unleash scientific innovation and grow the bioeconomy. BIO urged the subcommittee to ensure the Farm Bill energy title can unleash the potential growth of the bioeconomy, which can create tens of thousands of more jobs in rural America and promote billions of dollars of additional economic activity.

In the testimony, BIO discussed the need to revitalize rural economies and the value of the bio-based economy, and made recommendations for the next Farm Bill.

Download Full Comments Below
BIO-Jim-Greenwood-The-Next-Farm-Bill-Examining-Rural-Development-and-Energy-Programs
Download full comments below:
Discover More
On November 9, BIO submitted comments on the FDA Draft Guidance, Drug-Drug Interaction Assessment for Therapeutic Proteins. In the comments, BIO thanks the FDA for the opportunity to submit comments but requests that the Guidance include a…
On August 6, BIO submitted comments on the NMPA Draft Technical Guideline on Clinical Trials of Cellular Immunotherapy Products. In the comments, BIO thanks NMPA for the opportunity to submit comments but argues for a more robust commenting period…
October 30, 2020 Re: Docket No. FDA–2020-D-1564: FDA Draft Guidance, Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation. Dear Sir/Madam: The Biotechnology…